Lexeo Therapeutics Closes $95M Financing

March 17, 2024, 2:21 pm
LEXEO Therapeutics
LEXEO Therapeutics
Location: United States, New York
Employees: 11-50
Founded date: 2018
Total raised: $180M
Lexeo Therapeutics, a genetic medicine company, secures $95 million in private placement, extending runway into 2027. Co-led by Braidwell LP and Adage Capital Partners LP, with participation from various investors. Proceeds to fund clinical programs and general corporate purposes. Shares sold at $15.13 per share. Registration rights agreement in place. Lexeo focused on transforming treatment for cardiovascular diseases and Alzheimer's. Cautionary note on forward-looking statements. Contact for media and investor response provided. Source transparency emphasized by EIN Presswire.